Suppr超能文献

20-50 岁医护人员中针对脊灰病毒 1、2、3 型的中和抗体流行率。

PREVALENCE OF NEUTRALIZING ANTIBODIES AGAINST POLIOVIRUS 1, 2, AND 3 IN HEALTHCARE PROFESSIONALS AGED 20-50 YEARS.

机构信息

Medical School of Santa Casa de São Paulo, São Paulo, SP, Brazil.

Darcy Vargas Children's Hospital, Secretaria de Estado de Saúde, São Paulo, SP, Brazil.

出版信息

Rev Paul Pediatr. 2021 Feb 3;39:e2019354. doi: 10.1590/1984-0462/2021/39/2019354. eCollection 2021.

Abstract

OBJECTIVE

To describe the prevalence of neutralizing antibodies against poliovirus (PV1, PV2, and PV3) in blood samples of healthcare professionals aged 20 to 50 years.

METHODS

Health professionals who serve children at Darcy Vargas Children's Hospital and the Department of Pediatrics of Irmandade da Santa Casa de São Paulo. The sample size was calculated at 323 participants. The Mantel-Haenszel chi-square was used to verify differences between groups. The neutralization reaction detected human poliovirus antibodies. For susceptible individuals, vaccination with the inactivated+triple acellular polio vaccine was performed, and neutralizing antibodies were re-dosed after one week.

RESULTS

333 professionals were studied - 92.8% were immune to poliovirus 1, 86.5% to poliovirus 2, and 63.3% to poliovirus 3; 37% had titers less than 1:8 for any serotype, 5;1% had titers below 1:8 for all three. Vaccination with inactivated polio vaccine was performed for susceptible participants, and neutralizing antibodies were dosed after one week, showing increased titers for all polioviruses.

CONCLUSIONS

Despite the detection of a significant percentage of individuals with low poliovirus antibody titer, the challenge with vaccination demonstrated immune response compatible with poliovirus immunity.

摘要

目的

描述年龄在 20 至 50 岁之间的医护人员血液样本中针对脊髓灰质炎病毒(PV1、PV2 和 PV3)的中和抗体的流行情况。

方法

在达西·瓦加斯儿童医院和圣家儿童部为儿童服务的健康专业人员。样本量计算为 323 名参与者。采用 Mantel-Haenszel χ2 检验来检验组间差异。中和反应检测了人类脊髓灰质炎病毒抗体。对于易感个体,使用灭活+三价单价脊髓灰质炎疫苗进行了疫苗接种,并在一周后重新接种中和抗体。

结果

共研究了 333 名专业人员-92.8%对脊髓灰质炎病毒 1 具有免疫力,86.5%对脊髓灰质炎病毒 2 具有免疫力,63.3%对脊髓灰质炎病毒 3 具有免疫力;37%的人对任何血清型的抗体滴度低于 1:8,5%的人对所有三种血清型的抗体滴度均低于 1:8。对易感参与者进行了灭活脊髓灰质炎疫苗接种,一周后接种了中和抗体,所有脊髓灰质炎病毒的抗体滴度均增加。

结论

尽管检测到相当大比例的个体脊髓灰质炎病毒抗体滴度较低,但疫苗接种的挑战表明免疫反应与脊髓灰质炎病毒免疫力相兼容。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feb9/7870095/7ce6f8f3225b/1984-0462-rpp-39-e2019354-gf1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验